Savill Corrine
Officer at CGEM
- Sold, on record
- $2.5M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Feb 1, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CGEMCullinan Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CGEMPlan not statedJul 11, 2022 2022
Sold 40,000 shares at $13.33 ($533k)
Savill Corrine, Acting Chief Business Officer
Sold 19.1% of holdings ($2.8M position)169,615 shares leftFirst sale on recordFiling
- 2 Form 4 sale CGEMPlan not statedJul 19, 2022 +8 days
Sold 20,000 shares at $15.18 ($304k)
Savill Corrine, Acting Chief Business Officer
Sold 11.8% of holdings ($2.6M position)149,615 shares leftFiling
- 3 Form 144 notice CGEMNoticeJan 22, 2024 +552 days
Filed to sell 40,000 shares ($460k)
Savill Corrine, Officer
10b5-1 planFiling
- 4 Form 4 sale CGEMRoutineJan 23, 2024 +1 day
Sold 40,000 shares at $12.31 ($493k)
Savill Corrine, Chief Business Officer
10b5-1 planSold 19.4% of holdings ($2.5M position)165,990 shares leftFollows a Form 144Filing
- 5 Form 144 notice CGEMNoticeJan 29, 2024 +6 days
Filed to sell 40,000 shares ($523k)
Savill Corrine, Officer
10b5-1 plan1x usual sizeFiling
- 6 Form 4 sale CGEMRoutineJan 29, 2024 same day
Sold 40,000 shares at $14.09 ($564k)
Savill Corrine, Chief Business Officer
10b5-1 planSold 19.4% of holdings ($2.9M position)165,990 shares left1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice CGEMNoticeFeb 1, 2024 +3 days
Filed to sell 40,000 shares ($606k)
Savill Corrine, Officer
10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale CGEMRoutineFeb 1, 2024 same day
Sold 40,000 shares at $16.18 ($647k)
Savill Corrine, Chief Business Officer
10b5-1 planSold 19.4% of holdings ($3.3M position)165,990 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Feb 2, 2024 | CGEM | Chief Business Officer | Form 4 sale | 40,000 | $647k | 19.4% | Routine | SEC |
| Feb 1, 2024 | Feb 1, 2024 | CGEM | Officer | Form 144 notice | 40,000 | $606k | Notice | SEC | |
| Jan 29, 2024 | Jan 30, 2024 | CGEM | Chief Business Officer | Form 4 sale | 40,000 | $564k | 19.4% | Routine | SEC |
| Jan 29, 2024 | Jan 29, 2024 | CGEM | Officer | Form 144 notice | 40,000 | $523k | Notice | SEC | |
| Jan 23, 2024 | Jan 24, 2024 | CGEM | Chief Business Officer | Form 4 sale | 40,000 | $493k | 19.4% | Routine | SEC |
| Jan 22, 2024 | Jan 22, 2024 | CGEM | Officer | Form 144 notice | 40,000 | $460k | Notice | SEC | |
| Jul 19, 2022 | Jul 21, 2022 | CGEM | Acting Chief Business Officer | Form 4 sale | 20,000 | $304k | 11.8% | Plan not stated | SEC |
| Jul 11, 2022 | Jul 12, 2022 | CGEM | Acting Chief Business Officer | Form 4 sale | 40,000 | $533k | 19.1% | Plan not stated | SEC |